HVR Cardio, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that HVR Cardio Annuloplasty System initial study data will be presented as an e-poster at the Heart Valve Society Scientific Meeting 2017, taking place between 2-4 March at the Grimaldi Forum, Monaco.
E-poster P137 HVR Cardio Annuloplasty System: Results of an Early Feasibility Study in 11 patients after 513 Overall Combined follow-up Months will be shown in intervals during all three days across congress monitors.